More on FENC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (9.0 Score)

Upcoming Events

- Earnings (8/7/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Fennec Pharmaceuticals (NQ:FENC)
Delayed: 7.70 -0.23 (2.9%)
Prev. Close $7.93  
Open$7.80 
52 Wk High$ 
52 Wk Low$ 
Day High$8.05 
Day Low$7.51 
P/E N/A  
EPS$ 
Volume141,119 

Friends, Peers and Foes (?): FRX (more...)

Mar 5, 2026 04:16 PM Form S-8 FENNEC PHARMACEUTICALS
Mar 4, 2026 04:24 PM Form 8-K FENNEC PHARMACEUTICALS For: Mar 04
Mar 4, 2026 07:06 AM Fennec teams with Tampa General Hospital for PEDMARK study
Mar 4, 2026 07:05 AM Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute
Mar 3, 2026 04:06 PM Form 4 FENNEC PHARMACEUTICALS For: Feb 28 Filed by: Andrade Robert
Mar 3, 2026 04:05 PM Form 4 FENNEC PHARMACEUTICALS For: Feb 28 Filed by: Raykov Rosty
Mar 2, 2026 05:08 PM Form 144 FENNEC PHARMACEUTICALS Filed by: Raykov Rosty
Feb 20, 2026 04:03 PM Form 8-K FENNEC PHARMACEUTICALS For: Feb 20
Feb 20, 2026 07:03 AM Fennec presents real world data on PEDMARK for head and neck cancer patients
Feb 20, 2026 07:03 AM Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK® in Treating Adults with Head & Neck Cancers
View All Articles

Entities mentioned with FENC

View All Entities